These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25683060)

  • 1. Neurokinin B administration induces hot flushes in women.
    Jayasena CN; Comninos AN; Stefanopoulou E; Buckley A; Narayanaswamy S; Izzi-Engbeaya C; Abbara A; Ratnasabapathy R; Mogford J; Ng N; Sarang Z; Ghatei MA; Bloom SR; Hunter MS; Dhillo WS
    Sci Rep; 2015 Feb; 5():8466. PubMed ID: 25683060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurokinin 3 Receptor Antagonism Reveals Roles for Neurokinin B in the Regulation of Gonadotropin Secretion and Hot Flashes in Postmenopausal Women.
    Skorupskaite K; George JT; Veldhuis JD; Millar RP; Anderson RA
    Neuroendocrinology; 2018; 106(2):148-157. PubMed ID: 28380486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial.
    Prague JK; Roberts RE; Comninos AN; Clarke S; Jayasena CN; Nash Z; Doyle C; Papadopoulou DA; Bloom SR; Mohideen P; Panay N; Hunter MS; Veldhuis JD; Webber LC; Huson L; Dhillo WS
    Lancet; 2017 May; 389(10081):1809-1820. PubMed ID: 28385352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurokinin 3 Receptor Antagonism: A Novel Treatment for Menopausal Hot Flushes.
    Modi M; Dhillo WS
    Neuroendocrinology; 2019; 109(3):242-248. PubMed ID: 30504731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is core temperature the trigger of a menopausal hot flush?
    Jones H; Bailey TG; Barr DA; France M; Lucas RAI; Crandall CG; Low DA
    Menopause; 2019 Sep; 26(9):1016-1023. PubMed ID: 31453964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgens and estrogens in relation to hot flushes during the menopausal transition.
    Øverlie I; Moen MH; Holte A; Finset A
    Maturitas; 2002 Jan; 41(1):69-77. PubMed ID: 11809345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of neurokinin 3 receptor antagonist fezolinetant on hot flash-like symptoms in ovariectomized rats.
    Tahara A; Takamatsu H; Ohtake A; Tanaka-Amino K; Kaku S
    Eur J Pharmacol; 2021 Aug; 905():174207. PubMed ID: 34048742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women.
    Komesaroff PA; Black CV; Cable V; Sudhir K
    Climacteric; 2001 Jun; 4(2):144-50. PubMed ID: 11428178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of neurokinin B administration on reproductive hormone secretion in healthy men and women.
    Jayasena CN; Comninos AN; De Silva A; Abbara A; Veldhuis JD; Nijher GM; Ganiyu-Dada Z; Vaal M; Stamp G; Ghatei MA; Bloom SR; Dhillo WS
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E19-27. PubMed ID: 24170109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasomotor hot flushes and 24-hour ambulatory blood pressure in recently post-menopausal women.
    Tuomikoski P; Haapalahti P; Ylikorkala O; Mikkola TS
    Ann Med; 2010 Apr; 42(3):216-22. PubMed ID: 20384436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hot flushes during the menopause transition: a longitudinal study in Australian-born women.
    Guthrie JR; Dennerstein L; Taffe JR; Lehert P; Burger HG
    Menopause; 2005; 12(4):460-7. PubMed ID: 16037762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurokinin 3 receptor antagonism - the magic bullet for hot flushes?
    Prague JK; Dhillo WS
    Climacteric; 2017 Dec; 20(6):505-509. PubMed ID: 29040006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New advances in menopause symptom management.
    Koysombat K; McGown P; Nyunt S; Abbara A; Dhillo WS
    Best Pract Res Clin Endocrinol Metab; 2024 Jan; 38(1):101774. PubMed ID: 37076317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Not Available].
    Maione L; Christin-Maître S; Chanson P; Young J
    Ann Endocrinol (Paris); 2017 Oct; 78 Suppl 1():S31-S40. PubMed ID: 29157487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, controlled trial of a Chinese herbal formula (Er-Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women.
    Zhong LL; Tong Y; Tang GW; Zhang ZJ; Choi WK; Cheng KL; Sze SC; Wai K; Liu Q; Yu BX
    Menopause; 2013 Jul; 20(7):767-76. PubMed ID: 23793167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial function, but not carotid intima-media thickness, is affected early in menopause and is associated with severity of hot flushes.
    Bechlioulis A; Kalantaridou SN; Naka KK; Chatzikyriakidou A; Calis KA; Makrigiannakis A; Papanikolaou O; Kaponis A; Katsouras C; Georgiou I; Chrousos GP; Michalis LK
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1199-206. PubMed ID: 20080857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The menopausal hot flush--anything new?
    Sturdee DW
    Maturitas; 2008 May; 60(1):42-9. PubMed ID: 18384981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurokinin B pathway in the treatment of menopausal hot flushes.
    Anderson RA; Skorupskaite K; Sassarini J
    Climacteric; 2019 Feb; 22(1):51-54. PubMed ID: 30572747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms.
    Bouchard P; Panay N; de Villiers TJ; Vincendon P; Bao W; Cheng RJ; Constantine G
    Climacteric; 2012 Feb; 15(1):12-20. PubMed ID: 22066790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurokinin B and Neurokinin-3 Receptor Signaling: Promising Developments in the Management of Menopausal Hot Flushes.
    Modi M; Dhillo WS
    Semin Reprod Med; 2019 May; 37(3):125-130. PubMed ID: 31869840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.